COMMUNIQUÉS West-GlobeNewswire

AssistRx Completes Asset Acquisition from AllazoHealth, Strengthening its Advanced Tech + Talent Patient Support Services

02/04/2025 - 16:00

Tech-first therapy initiation and patient solutions provider enhances and augments services with artificial intelligence-powered patient engagement ORLANDO, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- AssistRx , the [...]

Sienna Senior Living Completes Previously Announced Acquisitions in Alberta and British Columbia

02/04/2025 - 15:32

MARKHAM, Ontario, April 02, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has finalized its previously announced acquisition of a portfolio of four [...]

Polyrizon Engages Leading Branding Firm for Strategic Brand Development

02/04/2025 - 15:05

Raanana, Israel, April 02, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ), a biotech company specializing in innovative intranasal hydrogels, today announced that it has entered into an agreement with a globally [...]

Nice Healthcare Partners with Business Health Trust to Expand in Washington

02/04/2025 - 15:00

Bringing affordable in-home and virtual primary care to Seattle, Tacoma, Everett, and Spokane MINNEAPOLIS, April 02, 2025 (GLOBE NEWSWIRE) -- Employers know that offering the right benefits isn’t just about staying [...]

Hydreight Technologies Named One of the Americas’ Fastest Growing Companies by Financial Times

02/04/2025 - 15:00

VANCOUVER, British Columbia and LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform transforming mobile and telehealth [...]

Prime Biome Reviews DON’T SKIP UNTIL SEE THIS for Preventing Fraud and Guaranteeing Reliability!

02/04/2025 - 14:46

ST. PETERSBURG, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- 2025, a popular supplement for reviving the gut and skin micro biota, Prime Biome has swept the wellness industry. Prime Biome is the greatest option for safe , [...]

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

02/04/2025 - 14:45

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James [...]

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

02/04/2025 - 14:30

HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that [...]

Alpha Tau Receives FDA Approval to Initiate a Trial for Patients with Recurrent Glioblastoma

02/04/2025 - 14:30

JERUSALEM, April 02, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , announced today that the FDA has approved an [...]

CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference

02/04/2025 - 14:30

BERKELEY HEIGHTS, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]

FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair

02/04/2025 - 14:30

HOUSTON, April 02, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics and [...]

Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025

02/04/2025 - 14:17

Event exploring the escalating threat of emerging infectious diseases Discussion covering going-private transaction with Aditxt, strategic growth partner HALIFAX, Nova Scotia, April 02, 2025 (GLOBE NEWSWIRE) -- Appili [...]

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

02/04/2025 - 14:05

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory [...]

Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program

02/04/2025 - 14:00

Rolling submission of BLA initiated for tividenofusp alfa; preparations ongoing for potential U.S. commercial launch in late 2025 or early 2026 Alignment through recent interactions with CDER on path to accelerated [...]

Immutep to Participate in Upcoming Investor Conferences

02/04/2025 - 14:00

SYDNEY, AUSTRALIA , April 02, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces [...]

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

02/04/2025 - 14:00

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for [...]

Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology’s 74th Annual Scientific Session and Expo

02/04/2025 - 14:00

BVA and Pressure Session Attracted 400+ Clinicians; Duke University Showcased Valuable New BVA Findings in Dedicated Poster Presentation Oak Ridge, TN, April 02, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR [...]

Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share

02/04/2025 - 14:00

SAN CARLOS, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Allakos Inc. (“Allakos”) (Nasdaq: ALLK), a biotechnology company that has been developing antibodies for the treatment of allergic, inflammatory and proliferative [...]

MUHC Foundation celebrates $200M Dream Big campaign milestone

02/04/2025 - 14:00

MONTREAL, April 02, 2025 (GLOBE NEWSWIRE) -- The McGill University Health Centre (MUHC) Foundation is proud to announce the successful completion of its ambitious Dream Big campaign, which has surpassed its $200 million [...]